US Coverage Dynamics for Alzheimer’s Diagnostics & Therapeutics: Lessons from the Field
Time: 8:00 am
day: Conference Day Two
Details:
- US Medicare coverage landscape to explore coverage discretion and policies for Alzheimer’s diagnostics and therapeutics
- Overviewing program for coverage with evidence development with the Medicare registry
- Access and reimbursement considerations when bringing a product to the US market: coverage, policy and reimbursement dynamics
